Sonnet BioTherapeutics’ $888M Crypto Treasury Bet on HYPE
Sonnet BioTherapeutics invests $888M in HYPE crypto, creating a new publicly traded company focused on crypto treasury management. High-growth potential but inherent crypto market risks apply.